F11R and neoplasm: Strikingly, the levels of plasma sJAM-A and EC-expressed JAM-A protein were reduced by the tumor inducers Tβ4 and TGF-β1, and the F11R/JAM-A antagonistic peptide 4D (P4D) showed a prospective barrier-protecting effect (145).